Pulmonary toxicity and cancer treatment.
Pulmonary toxicity is a serious potential complication of the use of cytotoxic drugs that can be debilitating and life threatening. Rapid recognition of this problem and its management are critical if morbidity is to be limited. This article discusses the mechanisms, common clinical features and risk factors for cytotoxic drug-induced pulmonary toxicity, and outlines general management principles.
Lung Cancer and Mesothelioma Research Group, Department of Medical Oncology, St Bartholomew's Hospital, London.
Dean A
DA
Fennell
Robin M
RM
Rudd
D000970:Antineoplastic Agents / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced* / Q000628:therapy; D011654:Pulmonary Edema / Q000139:chemically induced; D012307:Risk Factors
D000970:Antineoplastic Agents